Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Piani

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Journal of Medical Internet Research|February 13, 2020
A Physician-Completed Digital Tool for Evaluating Disease Progression (Multiple Sclerosis Progression Discussion Tool): Validation StudyTjalf Ziemssen, Daniela Piani-Meier, Bryan Bennett, et al.
Giornale Italiano Di Cardiologia (2006)|June 25, 2024
[Total artificial heart: past, present, and future]Gina Mazzeo, Alessandra Francica, Daniela Piani, et al.
Brain : a Journal of Neurology|December 1, 2025
Combined magnetic resonance imaging and serum analysis reveals distinct multiple sclerosis typesCharles Willard, Lemuel Puglisi, Daniele Ravi, et al.
Frontiers in Cardiovascular Medicine|August 28, 2023
Graft preservation in heart transplantation: current approachesAndrea Lechiancole, Sandro Sponga, Giovanni Benedetti, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|December 1, 2022
Rationale for Use of Sphingosine-1-Phosphate Receptor Modulators in COVID-19 Patients: Overview of Scientific EvidenceThomas Hach, Kasra Shakeri-Nejad, Marc Bigaud, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 26, 2021
Disability improvement as a clinically relevant outcome in clinical trials of relapsing forms of multiple sclerosisBruce Ac Cree, Jeffrey A Cohen, Anthony T Reder, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 25, 2024
Metabolic Syndrome and Heart Transplantation: An Underestimated Risk Factor?Sandro Sponga, Igor Vendramin, Veronica Ferrara, et al.
European Journal of Neurology|June 8, 2026
Progression to Wheelchair in Secondary Progressive Multiple Sclerosis and Impact of Siponimod: Post Hoc Analyses From the EXPAND StudyPatrick Vermersch, Sophie Arnould, Ralf Gold, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 21, 2015
Inclusion of brain volume loss in a revised measure of 'no evidence of disease activity' (NEDA-4) in relapsing-remitting multiple sclerosisLudwig Kappos, Nicola De Stefano, Mark S Freedman, et al.
JTCVS Open|August 25, 2022
Surgical management and outcomes in patients with acute type A aortic dissection and cerebral malperfusionIgor Vendramin, Miriam Isola, Daniela Piani, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Journal of Medical Internet Research|February 13, 2020
A Physician-Completed Digital Tool for Evaluating Disease Progression (Multiple Sclerosis Progression Discussion Tool): Validation StudyTjalf Ziemssen, Daniela Piani-Meier, Bryan Bennett, et al.
Giornale Italiano Di Cardiologia (2006)|June 25, 2024
[Total artificial heart: past, present, and future]Gina Mazzeo, Alessandra Francica, Daniela Piani, et al.
Brain : a Journal of Neurology|December 1, 2025
Combined magnetic resonance imaging and serum analysis reveals distinct multiple sclerosis typesCharles Willard, Lemuel Puglisi, Daniele Ravi, et al.
Frontiers in Cardiovascular Medicine|August 28, 2023
Graft preservation in heart transplantation: current approachesAndrea Lechiancole, Sandro Sponga, Giovanni Benedetti, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|December 1, 2022
Rationale for Use of Sphingosine-1-Phosphate Receptor Modulators in COVID-19 Patients: Overview of Scientific EvidenceThomas Hach, Kasra Shakeri-Nejad, Marc Bigaud, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 26, 2021
Disability improvement as a clinically relevant outcome in clinical trials of relapsing forms of multiple sclerosisBruce Ac Cree, Jeffrey A Cohen, Anthony T Reder, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 25, 2024
Metabolic Syndrome and Heart Transplantation: An Underestimated Risk Factor?Sandro Sponga, Igor Vendramin, Veronica Ferrara, et al.
European Journal of Neurology|June 8, 2026
Progression to Wheelchair in Secondary Progressive Multiple Sclerosis and Impact of Siponimod: Post Hoc Analyses From the EXPAND StudyPatrick Vermersch, Sophie Arnould, Ralf Gold, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 21, 2015
Inclusion of brain volume loss in a revised measure of 'no evidence of disease activity' (NEDA-4) in relapsing-remitting multiple sclerosisLudwig Kappos, Nicola De Stefano, Mark S Freedman, et al.
JTCVS Open|August 25, 2022
Surgical management and outcomes in patients with acute type A aortic dissection and cerebral malperfusionIgor Vendramin, Miriam Isola, Daniela Piani, et al.
Pageof 7